Home / News / India News / Article /
Maharashtra FDA cancels licence of Pune Ayurvedic medicine maker over safety violations
Updated On: 06 August, 2026 07:20 PM IST | Mumbai | mid-day online correspondent
According to the FDA Inducare Pharma allegedly failed to maintain proper records showing that approved Ayurvedic ingredients were used in manufacturing

According to the FDA, its inspectors found several shortcomings during their inspection of the manufacturing facility. Pic/FDA
The Maharashtra Food and Drug Administration (FDA) has cancelled the manufacturing licence of Pune-based Ayurvedic medicine manufacturer M/s Inducare Pharma Pvt. Ltd. after inspections allegedly revealed repeated regulatory violations and serious failures to meet safety and quality standards, an official statement said.
The company's manufacturing unit, located in the Jejuri MIDC area of Purandar taluka, was found to be in violation of the Drugs and Cosmetics Act, 1940, and Schedule-T Good Manufacturing Practices (GMP).


